An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report)

Background. Personalized therapy is becoming increasingly popular in oncological scenarios, not only based on molecular pharmacological targets, but also preventing any drug–drug–gene interaction (DDGI), which could lead to severe toxicities. Single nucleotide polymorphisms (SNPs), the individual ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Panebianco, Martina, Taurelli Salimbeni, Beatrice, Roberto, Michela, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161821/
https://www.ncbi.nlm.nih.gov/pubmed/34070464
http://dx.doi.org/10.3390/curroncol28030184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161821/
https://www.ncbi.nlm.nih.gov/pubmed/34070464
http://dx.doi.org/10.3390/curroncol28030184

Ejemplares similares